No data available
No data available
No data available
No data available
Shionogi's policy is to strive constantly to provide medicine of the best possible kind essential for the protection of the health of the people. Our mission, based on this policy, is to deliver pharmaceuticals that offer the greatest possible level of satisfaction to patients, their families, and healthcare providers and that improve quality of life for patients and their families. To achieve the above goal, we are constantly engaged in research, development, manufacturing, and marketing activities, with a primary focus on prescription drugs.
Simbec Research has over 35 years' experience in clinical drug development, specialising in healthy and patient volunteer studies. Simbec's Phase I-IIa services include: first into man phase I studies, single and multi-dose tolerability; proof of concept phase IIa studies; drug-drug interaction studies; bioavailability/bioequivalence studies; mass balance/ADME/microdosing; genotyping/phenotyping; bioanalytical services (including assay development); central laboratory services; and QTc studies. Support services include: regulatory, protocol and report writing, medical writing, project management, and data management and statistics pharmacokinetics. Niche services include: ophthalmic research, gamma scintigraphy, dermatology and respiratory.
No data available
SIP Cambridge is a regional skills group driving a local approach to addressing skills challenges, growing the skills pipeline and developing specialist STEM provision.. . Members of the SIP in Cambridge gain direct insights into what others are doing and the benefits they are gaining from their approach to skills, as well as keeping up-to-date with skills funding and policy.
No data available
SK pharmteco is a global CDMO specializing in the manufacture of Active Pharmaceutical Ingredients (APIs), advanced intermediates, Cell and Gene Therapy technologies, registered starting materials, and analytical services for the pharmaceutical industry from clinical to commercial production. Built on 80 years of experience in scaling manufacturing processes, SK pharmteco brings unmatched expertise and capacity to support clients at every stage of development in bringing life-changing medicines to patients. For your Cell and Gene Therapy needs, SK pharmteco unifies two of the best-in-class CDMOs on each side of the Atlantic: one in the South of Paris, France and one in the Philadelphia, PA area. Together, they offer a full range of services throughout the advanced therapies process, from R&D to manufacturing and commercialization. With extensive experience in mastering challenging chemistries, SK Pharmteco small molecule capabilities have been strategically developed to support a wide range of processes and technologies. Operating cGMP facilities across U.S., Europe, and Korea we have the capability and capacity to support drug substance needs at all scales of production, offering a unique experience in several specializations. From Analytical Method Development and Implementation to Method Validation and stability, our global network are fully equipped with compliant CGMP instrumentation geared toward product analysis and product release for integrated and standalone requirements.